Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01892722
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-06-09T00:05:00.700071+00:00
Published At
2018-09-19T00:00:00+00:00
Record Updated At
2026-06-08
Results Posted At
2018-09-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Multiple Sclerosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-06-08"
protocolSection.identificationModule.nctId
"NCT01892722"
protocolSection.identificationModule.officialTitle
"A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety \u0026 Efficacy of Daily Fingolimod vs Weekly Interferon \u03b2-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-09-19"

Study condition terms

  • Multiple Sclerosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.